Skip to main content

Advertisement

Log in

The incidence of newly diagnosed secondary cancer; sub-analysis the prospective study of the second-look procedure for transoral surgery in patients with T1 and T2 head and neck cancer

  • Original Article
  • Published:
International Journal of Clinical Oncology Aims and scope Submit manuscript

Abstract

Background

Our prospective study of patients with early T-stage head and neck cancer indicated a high incidence of newly diagnosed secondary malignancies during the follow-up period. We aimed to determine the incidence rate and risk factors of secondary malignancies in early-stage head and neck cancer patients.

Methods

We sub-analyzed the patient data of a previous study focusing on secondary cancer incidence. The endpoints were statistical analyses of risk factors and survival and incidence rates.

Results

The incidence rate of secondary cancer was 37%, the crude incidence of second primary cancers was 10.6 per 100 person-years, and the 5 year secondary cancer-free survival rate was 63%. The hypopharynx as the primary site was an independent significant predictive factor (odds ratio 3.96, 95% confidence interval 1.07–14.6, p = 0.039).

Conclusions

Early stages of laryngeal, oropharyngeal, and hypopharyngeal cancer had a risk of secondary cancer, especially hypopharyngeal cancer. Attention to the secondary cancer has to be paid during the follow-up period after controlling the early-stage disease. These findings highlight the need for awareness of the incidence of secondary cancer in cases of early-stage primary head and neck cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Availability of data and materials

The datasets used during the present study are available from the corresponding author upon request. All data generated or analyzed during this study are included in this published article.

References

  1. Cancer Registry and Statistics. Cancer Information Service, National Cancer Center, Japan. https://ganjoho.jp/reg_stat/

  2. Vikram B (1984) Changing patterns of failure in advanced head and neck cancer. Arch Otolaryngol 110:564–565

    Article  CAS  Google Scholar 

  3. Vokes EE, Kies M, Haraf DJ et al (1995) Induction chemotherapy followed by concomitant chemoradiotherapy for advanced head and neck cancer: impact on the natural history of the disease. J Clin Oncol 13:876–883

    Article  CAS  Google Scholar 

  4. Khuri FR, Lippman SM, Spitz MR et al (1997) Molecular epidemiology and retinoid chemoprevention of head and neck cancer. J Natl Cancer Inst 89:199–211

    Article  CAS  Google Scholar 

  5. Dammann F, Horger M, Mueller-Berg M et al (2005) Rational diagnosis of squamous cell carcinoma of the head and neck region: comparative evaluation of CT, MRI, and 18FDG PET. AJR Am J Roentgenol 184:1326–1331

    Article  Google Scholar 

  6. Watanabe A, Taniguchi M, Tsujie H et al (2008) The value of narrow band imaging endoscope for early head and neck cancers. Otolaryngol Head Neck Surg 138:446–451

    Article  Google Scholar 

  7. Morita M, Saeki H, Ito S et al (2014) Surgical strategies for esophageal cancer associated with head and neck cancer. Surg Today 44:1603–1610

    Article  Google Scholar 

  8. Nishimura G, Sano D, Arai Y et al (2019) A prospective clinical trial of the second-look procedure for transoral surgery in patients with T1 and T2 laryngeal, oropharyngeal, and hypopharyngeal cancer. Cancer Med 8:7197–7206

    Article  Google Scholar 

  9. Nishimura G, Sano D, Yabuki K et al (2017) The second-look procedure for transoral videolaryngoscopic surgery for T1 and T2 laryngeal, oropharyngeal, and hypopharyngeal cancer patients: protocol for nonrandomized clinical trial. JMIR Res Protoco 6:e235

    Article  Google Scholar 

  10. Bhatia AK, Lee JW, Pinto HA et al (2017) Double-blind, randomized phase 3 trial of low-dose 13-cis retinoic acid in the prevention of second primaries in head and neck cancer: long-term follow-up of a trial of the eastern cooperative oncology Group-ACRIN Cancer Research Group (C0590). Cancer 123:4653–4662

    Article  CAS  Google Scholar 

  11. Rogers SN, Swain A, Carroll C et al (2019) Incidence, timing, presentation, treatment, and outcomes of second primary head and neck squamous cell carcinoma after oral cancer. Br J Oral Maxillofac Surg 57:1074–1080

    Article  CAS  Google Scholar 

  12. Ord RA, Isaiah A, Dyalram D et al (2018) Is long-term follow-up mandatory for stage i oral tongue cancer? J Oral Maxillofac Surg 76:2676–2683

    Article  Google Scholar 

  13. Sobin L, Wittekind C (2009) TNM Classification of malignant tumours, 7th edn. Wiley-Liss, New York

    Google Scholar 

  14. Cooper JS, Pajak TF, Rubin P et al (1989) Second malignancies in patients who have head and neck cancer: incidence, effect on survival and implications based on the RTOG experience. Int J Radiat Oncol Biol Phys 17:449–456

    Article  CAS  Google Scholar 

  15. McDonald S, Haie C, Rubin P et al (1989) Second malignant tumors in patients with laryngeal carcinoma: diagnosis, treatment, and prevention. Int J Radiat Oncol Biol Phys 17:457–465

    Article  CAS  Google Scholar 

  16. Licciardello JT, Spitz MR, Hong WK (1989) Multiple primary cancer in patients with cancer of the head and neck: second cancer of the head and neck, esophagus, and lung. Int J Radiat Oncol Biol Phys 17:467–476

    Article  CAS  Google Scholar 

  17. Lee DW, Roh JL, Baek S et al (2013) Second cancer incidence, risk factor, and specific mortality in head and neck squamous cell carcinoma. Otolaryngol Head Neck Surg 149:579–586

    Article  Google Scholar 

  18. Xiang M, Chang DT, Pollom EL (2020) Second cancer risk after primary cancer treatment with three-dimentional conformal, intensity-modulated, or proton beam radiation therapy. Cancer 126(15):3560–3568

    Article  Google Scholar 

  19. Shinozaki T, Katada C, Shiga K et al (2020) Effectiveness of planned surveillance for detecting second primary head and neck cancers after endoscopic resection of esophageal squamous cell carcinoma. Jpn J Clin Oncol. https://doi.org/10.1093/jjco/hyaa087[Epub ahead of print]

    Article  PubMed  Google Scholar 

  20. Yokoyama A, Kumagai Y, YokoyamaT, et al (2009) Health risk appraisal models for mass screening for esophageal and pharyngeal cancer: an endoscopic follow-up study of cancer-free Japanese men. Cancer Epidemiol Biomarkers Prev 18:651–655

    Article  Google Scholar 

  21. Yamashita Y, Ikegami T, Suzuki M et al (2019) Hypopharyngeal cancer risk in Japanese: genetic polymorphisms related to the metabolism of alcohol- and tobacco-associated carcinogens. J Cancer Res Ther 15:556–563

    Article  CAS  Google Scholar 

  22. Lippman SM, Hong WK (1989) Second malignant tumors in head and neck squamous cell carcinoma: the overshadowing threat for patients with early-stage disease. Int J Radiat Oncol Biol Phys 17:691–694

    Article  CAS  Google Scholar 

  23. The Cancer Institute Hospital of JFCR, Japan. https://www.jfcr.or.jp

Download references

Funding

No funding was received.

Author information

Authors and Affiliations

Authors

Contributions

GN and NO conceived and statistical analyzed this study, and edited this manuscript. GN, NO, DS and YA designed this study. GN, TH, HT, YK, KT and TW acquired, analyzed and interpreted the date. GN, DS and YA evaluated the quality control of data and algorithms. GN prepared this manuscript and all authors reviewed and approved the final version of the manuscript.

Corresponding author

Correspondence to Goshi Nishimura.

Ethics declarations

Competing interests

The authors declare no conflicts of interest.

Ethics approval and consent to participate

Ethical approval for the study was obtained from the Yokohama City University Institutional Review Board (#B131107003). Written informed consent was obtained from the study participants to publish of their data.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nishimura, G., Sano, D., Arai, Y. et al. The incidence of newly diagnosed secondary cancer; sub-analysis the prospective study of the second-look procedure for transoral surgery in patients with T1 and T2 head and neck cancer. Int J Clin Oncol 26, 59–65 (2021). https://doi.org/10.1007/s10147-020-01779-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10147-020-01779-7

Keywords

Navigation